Vaping vs. Smoking: What Research Actually Shows About Respiratory Health
Why Switching From Smoking to Vaping Improves Respiratory Health
People who quit smoking by switching to vaping often report fewer respiratory infections and less persistent coughing. This isn’t a coincidence—it’s a measurable shift in respiratory outcomes. But understanding why requires separating what vaping actually does from what simply not smoking does.
The Immediate Win: Removing Tobacco Smoke
Cigarette smoke damages the respiratory system through heat, tar, and thousands of toxic compounds. Smokers experience chronic inflammation, impaired immune response in the lungs, and heightened susceptibility to infections. When someone quits smoking—whether they switch to vaping or not—many of these harms begin to reverse.
The baseline improvement comes from stopping smoking itself, not from any protective benefit of vaping. People who quit smoking cold turkey also see improved respiratory function over time. The difference is that smokers who switch to vaping are more likely to stick with the change, which allows those improvements to compound.
The Bactericidal Property: Propylene Glycol
Vaping liquid typically contains propylene glycol as a carrier for nicotine and flavorings. Research suggests propylene glycol has bactericidal properties—meaning it can kill bacteria. This ingredient, inhaled regularly, may provide an additional layer of protection against certain respiratory infections beyond simply removing tobacco smoke exposure.
This mechanism could explain why people like the original post feel they’re getting sick less often. It’s not that vaping prevents infections in the way a vaccine might, but rather that the inhaled propylene glycol creates an environment less hospitable to bacterial colonization in the airways.
However, this finding comes primarily from laboratory research and theoretical analysis. Large-scale human studies confirming this protective effect are still lacking.
The Complication: Vaping Has Its Own Respiratory Risks
The picture becomes murkier when we look at vaping as a standalone activity, separate from the smoking-to-vaping comparison. Numerous studies have found that vaping carries respiratory harms:
- Non-smokers who vape report higher rates of persistent cough, chest congestion, and respiratory symptoms than those who don’t vape
- Chemicals in vape aerosol—including formaldehyde and acrolein—can damage lung tissue and interfere with the lungs’ natural defense mechanisms
- People who began vaping as non-smokers show elevated risk for asthma, chronic bronchitis, and respiratory disease compared to never-users
- Vaping impairs immune response in airway tissue, potentially increasing susceptibility to viral infections
One large study found that current e-cigarette users had a 43% increased risk of developing respiratory disease. That’s a material increase in risk, even if it’s lower than the risk from continued smoking.
What We Actually Know About Infections
The original post’s observation—that they haven’t had a respiratory infection in 13 years—is a strong anecdotal account. But the scientific evidence on whether vaping specifically prevents infections is inconclusive. A major systematic review of respiratory health effects found “inconsistent findings” on respiratory infection risk in current vapers compared to non-users.
Laboratory studies suggest vaping increases susceptibility to viral infection in the short term. Real-world studies in humans don’t show a consistent pattern. The evidence remains sparse and uncertain, with researchers acknowledging the need for more long-term human studies.
What we can say with confidence: complete switching from smoking to vaping produces respiratory improvements compared to continued smoking. Whether those improvements are large, last long-term, or are fully attributable to stopping smoking versus vaping’s specific effects remains unclear.
The Bottom Line
If you’ve been smoking for years and switched to vaping, fewer respiratory infections is a reasonable outcome. You’ve removed a major source of respiratory damage. The propylene glycol in vape liquid may offer additional protection. But vaping isn’t a health intervention—it’s harm reduction relative to smoking. It still carries respiratory risks that non-smokers don’t have.
The fact that this person hasn’t gotten sick in 13 years is worth noticing. It’s also worth recognizing that some of that benefit comes from not smoking, and the rest remains partially unexplained by current research.
Sources
- pmc.ncbi.nlm.nih.gov
- pmc.ncbi.nlm.nih.gov
- respiratory-therapy.com
- bu.edu
- pmc.ncbi.nlm.nih.gov
- michiganmedicine.org
- ncbi.nlm.nih.gov
- ncbi.nlm.nih.gov
